Burkitt's lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most ...
The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
In this MedPage Today video, Taylor Brooks, MD, of the Cleveland Clinic Cancer Institute, discusses real-world survival ...
Dr Kami Maddocks reflects on fresh data, such as the new epcoritamab combo approval, evolving CD19 sequencing data, and ...
Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...
MedPage Today on MSN
Bispecifics before CAR-T may be best-bet sequence for large B-cell lymphoma
The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...
Check out our weekly list of new fundraisers from Lend A Hand Up, a nonprofit crowdfunding site supporting families in Cass, ...
At the recent American Society of Hematology (ASH) annual meeting, phase II data were presented on a bispecific antibody for ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
Life changes post-diagnosis included early retirement due to immune compromise and personal milestones like adopting a new ...
To diagnose non-Hodgkin‘s lymphoma, doctors may use blood tests, biopsies, and imaging scans such as CT scans or MRIs. These tests help doctors confirm the presence of the disease and plan the right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback